Editor’s Note: This article is the second in our three-part series, Federal Antitrust Enforcement in Health Care: 2023 Year in Review. (Click here to read part 1.) The series is based.
In 2023, the DOJ continued its aggressive criminal antitrust enforcement agenda in health care, with mixed results in labor markets. In speeches, the DOJ asserted that its commitment to.
Editor’s Note: The article below is the first in our three-part series, Federal Antitrust Enforcement in Health Care: 2023 Year in Review. The series is based on our recent webinar,.
Department of Justice, Antitrust Division announced withdrawal of three policy statements on health care antitrust enforcement, and FTC may do the same. This may be most significant antitrust enforcement development under Biden Administration.